Tom M. Hillary

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial.

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial.

Journal: The Lancet regional health. Europe

Published: January 29, 2026

Personalized Medicine in Psoriasis - A Long Road Ahead?

Personalized Medicine in Psoriasis - A Long Road Ahead?

Journal: Psoriasis (Auckland, N.Z.)

Published: January 10, 2026

Hidradenitis suppurativa patients exhibit a distinctive and highly individualized skin virome.

Hidradenitis suppurativa patients exhibit a distinctive and highly individualized skin virome.

Journal: mSystems

Published: December 15, 2025

Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based review.

Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based review.

Journal: Frontiers in pharmacology

Published: November 12, 2025

Family history in melanoma risk: Revisiting criteria for surveillance.

Family history in melanoma risk: Revisiting criteria for surveillance.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 25, 2025

Prolonged disease remission of the chronic immunological skin disorder hidradenitis suppurativa with adjunctive bacteriophage therapy.

Prolonged disease remission of the chronic immunological skin disorder hidradenitis suppurativa with adjunctive bacteriophage therapy.

Journal: Nature communications

Published: July 11, 2025

Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study).

Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study).

Journal: Vaccines

Published: September 11, 2024

Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One-year outcomes from the international noninterventional CIMREAL study.

Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One-year outcomes from the international noninterventional CIMREAL study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 18, 2024

The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic review.

The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic review.

Journal: JAAD international

Published: June 15, 2024

Belgian recommendations for managing psoriasis in a changing treatment landscape.

Belgian recommendations for managing psoriasis in a changing treatment landscape.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 06, 2024

A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State.

A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State.

Journal: Dermatology and therapy

Published: January 12, 2024

Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis.

Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 29, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026